{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:32:06Z","timestamp":1763620326266,"version":"3.41.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/md.0000000000007191","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T15:55:45Z","timestamp":1497455745000},"page":"e7191","source":"Crossref","is-referenced-by-count":14,"title":["A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome"],"prefix":"10.1097","volume":"96","author":[{"given":"Shi-Sheng","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Qiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Chen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-47-20210226","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s40746-016-0044-x","article-title":"Nephrotic syndrome: updates and approaches to treatment","volume":"2","author":"Rheault","year":"2016","journal-title":"Curr Treat Options Peds"},{"key":"R2-47-20210226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R3-47-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R4-47-20210226","first-page":"104","article-title":"Long-term outcomes in children with steroid-resistant nephrotic syndrome treated with calcineurin inhibitors","volume":"27","author":"Beins","year":"2015","journal-title":"Front Pediatr"},{"key":"R5-47-20210226","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00467-015-3058-x","article-title":"Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome","volume":"30","author":"Cil","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"R6-47-20210226","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: when and how","volume":"31","author":"Lovric","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R7-47-20210226","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40620-016-0315-4","article-title":"Lessons from genetics: is it time to revise the therapeutic approach to children with steroid-resistant nephrotic syndrome?","volume":"29","author":"Becherucci","year":"2016","journal-title":"J Nephrol"},{"key":"R8-47-20210226","doi-asserted-by":"crossref","first-page":"339","DOI":"10.18388\/abp.2013_1990","article-title":"Molecular basis of mechanisms of steroid resistance in children with nephrotic syndrome","volume":"60","author":"Swierczewska","year":"2013","journal-title":"Acta Biochim Pol"},{"key":"R9-47-20210226","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s12098-016-2142-y","article-title":"P-glycoprotein activity in steroid-responsive vs. steroid-resistant nephrotic syndrome","volume":"83","author":"Badr","year":"2016","journal-title":"Indian J Pediatr"},{"key":"R10-47-20210226","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00467-006-0187-2","article-title":"Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response","volume":"21","author":"Wasilewska","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R11-47-20210226","first-page":"218","article-title":"Resistance to therapy in primary nephrotic syndrome: effect of MDR1 gene activity [Polish]","volume":"8","author":"Stachowski","year":"2000","journal-title":"Pol Merkur Lekarski"},{"key":"R12-47-20210226","first-page":"154","article-title":"Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome","volume":"5","author":"Youssef","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"R13-47-20210226","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-47-20210226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gene.2013.08.045","article-title":"Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids","volume":"530","author":"Youssef","year":"2013","journal-title":"Gene"},{"key":"R15-47-20210226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12659\/MSM.891366","article-title":"MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results","volume":"21","author":"Cizmarikova","year":"2015","journal-title":"Med Sci Monit"},{"key":"R16-47-20210226","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1093\/ndt\/gfr150","article-title":"MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children","volume":"26","author":"Jafar","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R17-47-20210226","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00467-012-2182-0","article-title":"Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome","volume":"27","author":"Chiou","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R18-47-20210226","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R19-47-20210226","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.","volume":"98","year":"1981","journal-title":"J Pediatr"},{"key":"R20-47-20210226","first-page":"479","article-title":"Diagnosis and management of nephrotic syndrome in adults","volume":"93","author":"Kodner","year":"2016","journal-title":"Am Fam Physician"},{"key":"R21-47-20210226","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R23-47-20210226","doi-asserted-by":"crossref","first-page":"e59495","DOI":"10.1371\/journal.pone.0059495","article-title":"The association between gene polymorphism of TCF7L2 and type 2 diabetes in Chinese Han population: a meta-analysis","volume":"8","author":"Dou","year":"2013","journal-title":"PLoS One"},{"key":"R24-47-20210226","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11033-011-0735-0","article-title":"A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis","volume":"39","author":"Wang","year":"2012","journal-title":"Mol Biol Rep"},{"key":"R25-47-20210226","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scan J Stat"},{"key":"R26-47-20210226","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"key":"R27-47-20210226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gepi.20048","article-title":"Heterogeneity testing in meta-analysis of genome searches","volume":"28","author":"Zintzaras","year":"2005","journal-title":"Genet Epidemiol"},{"key":"R28-47-20210226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R29-47-20210226","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R30-47-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R31-47-20210226","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00467-006-0275-3","article-title":"MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children","volume":"22","author":"Wasilewska","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R32-47-20210226","doi-asserted-by":"crossref","first-page":"1417456","DOI":"10.1155\/2016\/1417456","article-title":"Single nucleotide polymorphisms in pediatric idiopathic nephrotic syndrome","volume":"2016","author":"Suvanto","year":"2016","journal-title":"Int J Nephrol"},{"key":"R33-47-20210226","first-page":"1","article-title":"ABCB1 polymorphisms and steroid treatment in children with idiopathic nephrotic syndrome","volume":"10","author":"Safan","year":"2016","journal-title":"Br J Biomed Sci"},{"key":"R34-47-20210226","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/gtmb.2015.0077","article-title":"Association of ACE and MDR1 gene polymorphisms with steroid resistance in children with idiopathic nephrotic syndrome","volume":"19","author":"Dhandapani","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"R35-47-20210226","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00467-011-1903-0","article-title":"Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome","volume":"26","author":"Choi","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R36-47-20210226","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/0008-5472.CAN-13-2064","article-title":"MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer","volume":"74","author":"Fung","year":"2014","journal-title":"Cancer Res"},{"key":"R37-47-20210226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance","volume":"75","author":"Marzolini","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R38-47-20210226","first-page":"445","article-title":"MDR1 (ABCB1) polymorphisms: functional effects and clinical implications","volume":"65","author":"Brambila-Tapia","year":"2013","journal-title":"Rev Invest Clin"},{"key":"R39-47-20210226","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40262-015-0267-1","article-title":"Impact of genetic polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on drug disposition and potential clinical implications: update of the literature","volume":"54","author":"Wolking","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"R40-47-20210226","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00431-006-0177-1","article-title":"Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids","volume":"165","author":"Wasilewska","year":"2006","journal-title":"Eur J Pediatr"},{"key":"R41-47-20210226","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-200X.2008.02541.x","article-title":"Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome","volume":"50","author":"Funaki","year":"2008","journal-title":"Pediatr Int"},{"key":"R42-47-20210226","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"R43-47-20210226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/14622416.8.8.1075","article-title":"Silent SNPs: impact on gene function and phenotype","volume":"8","author":"Komar","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R44-47-20210226","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1158\/0008-5472.CAN-07-2377","article-title":"Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer","volume":"60","author":"Sauna","year":"2007","journal-title":"Cancer Res"},{"key":"R45-47-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mcp.2001.117412","article-title":"Identification of functionally variant MDR1 alleles among European Americans and African Americans","volume":"70","author":"Kim","year":"2001","journal-title":"Clin Pharmacol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:25:31Z","timestamp":1750350331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201706160-00047"}},"subtitle":["Susceptibility and steroid responsiveness"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":44,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007191","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}